Optimal treatment of acute uncomplicated type B aortic dissection: Will a randomized trial ever be conducted?
Journal of Vascular Surgery · 2023
DOI: 10.1016/j.jvs.2022.12.065 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Vascular Surgery, 2023. Verfasst von Keith D Calligaro. Beteiligte Einrichtung: Section of Vascular Surgery, Pennsylvania Hospital, Philadelphia, PA. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Aortic Dissection, Blood Vessel Prosthesis Implantation, Endovascular Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Section of Vascular Surgery, Pennsylvania Hospital, Philadelphia, PA.
Zitieren
APA
Calligaro, K. D. (2023). Optimal treatment of acute uncomplicated type B aortic dissection: Will a randomized trial ever be conducted?. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2022.12.065
Vancouver
Calligaro KD. Optimal treatment of acute uncomplicated type B aortic dissection: Will a randomized trial ever be conducted?. Journal of Vascular Surgery. 2023. doi:10.1016/j.jvs.2022.12.065
BibTeX
@article{Calligaro2023,
author = {Calligaro, Keith D},
title = {Optimal treatment of acute uncomplicated type B aortic dissection: Will a randomized trial ever be conducted?},
journal = {Journal of Vascular Surgery},
year = {2023},
doi = {10.1016/j.jvs.2022.12.065}
}
EUVIMED